The TESTBREAST study: early detection of breast cancer in women at high risk of developing breast cancer with serum biomarkers.

The TESTBREAST study: early detection of breast cancer in women at high risk of developing breast cancer with serum biomarkers. - The TESTBREAST study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON53091

Enrollment

1193

Registered

2017-05-31

Start date

2010-06-01

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - women - 25-75 years old - indication for frequent surveillance (twice a year) because of genetic or familial high risk of developing breast cancer or life time risk of more 15 percent.

Exclusion criteria

Exclusion criteria: - breast cancer in medical history - malignancy in de past 10 years (excl. basalcell carcinoma)

Design outcomes

Primary

Measure	Time frame
Early detection of breast cancer by analysing protein and glycan profiles.	—

Secondary

Measure	Time frame
To analyse the prognostic value of protein and glycan profiles secundary parameters are 5 years survival, disease free period and distant mestastasis	—

Countries

Netherlands

Outcome results